Lee Financial CO Edwards Lifesciences Corp Transaction History

Lee Financial CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $1,465 - $1,697	18 New	18 $1,000
Q3 2022 Nov 01, 2022	SELL	$82.37 - $107.29 $22,322 - $29,075	-271 Reduced 97.48%	7 $1,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $1,124 - $1,667	-13 Reduced 4.47%	278 $26,000
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $2,243 - $2,823	22 Added 8.18%	291 $34,000
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $531 - $653	5 Added 1.89%	269 $35,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $10,127 - $13,543	176 Added 200.0%	264 $18,000
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $3,193 - $3,417	88	88 $10,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.